IMU 0.00% 4.9¢ imugene limited

Media Thread, page-15087

  1. 3,148 Posts.
    lightbulb Created with Sketch. 1601
    Imugene committed to preclinical trials with Renovo tech back in Jul 23 for a period of four months. It was stated in the Ann - they would expand the partnership upon success.
    I understand clinical trials can take time and timelines blow out - but this is preclinical work (so no patient recruitment etc required) that should have been finished in around Nov 23.

    So for almost a year later we have heard nothing about it and nothing about any expansion of patnership.

    So I am not sure this will happen anymore, perhaps it will, however IMU has a habit of going quiet (and not announcing something) and it just falling off the radar when they have gone a different route - just like collabs with Eureka + Cellularity.

    DYOR and all that
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.